Phylloceuticals is a company with a revolutionary business model  and a mission to provide pharmaceuticals as a service technology to our customers. We call it PhAAST(TM) (PHarmaceuticals as a Service Technology). Using the power of plant-made pharma technology, Phylloceuticals was formed to address breakdowns in national and international pharmaceutical supply chains that were made evident during the Covid-19 pandemic. It is now a global public health priority to strengthen these national supply chains. An uninterrupted supply of essential medicines that are safe, meet standards for quality, and are beneficial to health is a priority for every country and region.  OVERVIEW • A company with a single mission: provide global access to healthcare by bringing a service technology approach to pharmaceuticals called PhAAST • Uses plant-made pharma technology which offers superior cost structures, low risk of toxicity, and a much quicker response time for drug development  • Phylloceuticals’ mission is to nucleate companies to manufacture pharmaceuticals and serve national/international markets which currently struggle with access to drugs taken for granted elsewhere  THE CHALLENGE 
  • COVID has exposed a supply chain breakdown globally • Goal: An uninterrupted supply of essential medicines that are safe and meet quality standards and are available to all, no matter where • National Supply Chain improvement is a priority for most countries and regions • There is a global need for pharma security and product tracing • This investment opportunity is being launched to address these vulnerabilities and enhance the world’s ability to supply biologics to all populations  The key features of PhAAST(TM): Low cost facilities and operations Continuous improvements in plant - made pharmaceutical manufacturing systems Continuously optimized product vectors for improved gene expression Centralized expert data management of quality control systems and product tracing through